Literature DB >> 21062960

Transaldolase exchange and its effects on measurements of gluconeogenesis in humans.

Rita Basu1, Cristina Barosa, Ananda Basu, Vishwanath Pattan, Ahmed Saad, John Jones, Robert Rizza.   

Abstract

The deuterated water method is used extensively to measure gluconeogenesis in humans. This method assumes negligible exchange of the lower three carbons of fructose 6-phsophate via transaldolase exchange since this exchange will result in enrichment of carbon 5 of glucose in the absence of net gluconeogenesis. The present studies tested this assumption. ²H₂O and acetaminophen were ingested and [1-¹³C]acetate infused in 11 nondiabetic subjects after a 16-h fast. Plasma and urinary glucuronide enrichments were measured using nuclear magnetic resonance spectroscopy before and during a 0.35 mU·kg FFM⁻¹·min⁻¹ insulin infusion. Rates of endogenous glucose production measured with [3-³H]- and [6,6-²H₂]glucose did not differ either before (14.0 ± 0.7 vs. 13.8 ± 0.7 μmol·kg⁻¹·min⁻¹) or during the clamp (10.4 ± 0.9 vs. 10.9 ± 0.7 μmol·kg⁻¹·min⁻¹), consistent with equilibration and quantitative removal of tritium during triose isomerase exchange. Plasma [3-¹³C] glucose-to-[4-¹³C]glucose and urinary [3-¹³C] glucuronide-to-[4-¹³C]glucuronide ratios were <1.0 (P < 0.001) in all subjects both before (0.66 ± 0.04 and 0.60 ± 0.04) and during (059 ± 0.05 and 0.56 ± 0.06) the insulin infusion, respectively, indicating that ∼35-45% of the labeling of the 5th carbon of glucose by deuterium was due to transaldolase exchange rather than gluconeogenesis. When corrected for transaldolase exchange, rates of gluconeogenesis were lower (P < 0.001) and glycogenolysis higher (P < 0.001) than uncorrected rates both before and during the insulin infusion. In conclusion, assuming negligible dilution by glycerol and near-complete triose isomerase equilibration, these data provide strong experimental evidence that transaldolase exchange occurs in humans, resulting in an overestimate of gluconeogenesis and an underestimate of glycogenolysis when measured with the ²H₂O method. Use of appropriate ¹³C tracers provides a means of correcting for transaldolase exchange.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21062960      PMCID: PMC3043622          DOI: 10.1152/ajpendo.00403.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  35 in total

1.  Energetics of triosephosphate isomerase: the appearance of solvent tritium in substrate glyceraldehyde 3-phosphate and in product.

Authors:  S J Fletcher; J M Herlihy; W J Albery; J R Knowles
Journal:  Biochemistry       Date:  1976-12-14       Impact factor: 3.162

2.  The reciprocal pool model for the measurement of gluconeogenesis by use of [U-(13)C]glucose.

Authors:  M W Haymond; A L Sunehag
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-01       Impact factor: 4.310

3.  Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.

Authors:  A Gastaldelli; E Toschi; M Pettiti; S Frascerra; A Quiñones-Galvan; A M Sironi; A Natali; E Ferrannini
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

4.  Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.

Authors:  M Roden; H Stingl; V Chandramouli; W C Schumann; A Hofer; B R Landau; P Nowotny; W Waldhäusl; G I Shulman
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

5.  Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity.

Authors:  A Basu; R Basu; P Shah; A Vella; C M Johnson; M Jensen; K S Nair; W F Schwenk; R A Rizza
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

6.  Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.

Authors:  A Gastaldelli; S Baldi; M Pettiti; E Toschi; S Camastra; A Natali; B R Landau; E Ferrannini
Journal:  Diabetes       Date:  2000-08       Impact factor: 9.461

7.  Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.

Authors:  G Boden; X Chen; T P Stein
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-01       Impact factor: 4.310

8.  Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.

Authors:  A Vella; P Shah; R Basu; A Basu; M Camilleri; W F Schwenk; R A Rizza
Journal:  Diabetologia       Date:  2001-06       Impact factor: 10.122

9.  Quantification of hepatic transaldolase exchange activity and its effects on tracer measurements of indirect pathway flux in humans.

Authors:  John G Jones; Paula Garcia; Cristina Barosa; Teresa C Delgado; M Madalena Caldeira; Luisa Diogo
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

10.  Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes.

Authors:  R Basu; A Basu; V Chandramouli; B Norby; B Dicke; P Shah; O Cohen; B R Landau; R A Rizza
Journal:  Diabetologia       Date:  2008-09-04       Impact factor: 10.460

View more
  8 in total

1.  Mechanisms Underlying the Pathogenesis of Isolated Impaired Glucose Tolerance in Humans.

Authors:  Ron T Varghese; Chiara Dalla Man; Anu Sharma; Ivan Viegas; Cristina Barosa; Catia Marques; Meera Shah; John M Miles; Robert A Rizza; John G Jones; Claudio Cobelli; Adrian Vella
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

2.  Acetaminophen glucuronide and plasma glucose report identical estimates of gluconeogenesis and glycogenolysis for healthy and prediabetic subjects using the deuterated water method.

Authors:  Cristina Barosa; John G Jones; Robert Rizza; Ananda Basu; Rita Basu
Journal:  Magn Reson Med       Date:  2012-09-28       Impact factor: 4.668

3.  Use of (2)H(2)O for estimating rates of gluconeogenesis: determination and correction of error due to transaldolase exchange.

Authors:  Jeffrey D Browning; Shawn C Burgess
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-02       Impact factor: 4.310

4.  Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis.

Authors:  S Kehlenbrink; S Koppaka; M Martin; R Relwani; M-H Cui; J-H Hwang; Y Li; R Basu; M Hawkins; P Kishore
Journal:  Diabetologia       Date:  2012-07-31       Impact factor: 10.122

5.  Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.

Authors:  Rita Basu; Cristina Barosa; John Jones; Simmi Dube; Rickey Carter; Ananda Basu; Robert A Rizza
Journal:  J Clin Endocrinol Metab       Date:  2013-01-23       Impact factor: 5.958

6.  Effects of transaldolase exchange on estimates of gluconeogenesis in type 2 diabetes.

Authors:  Aman Rajpal; Simmi Dube; Filipa Carvalho; Ana Rita Simoes; Angelo Figueiredo; Ananda Basu; John Jones; Rita Basu
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-06-04       Impact factor: 4.310

7.  Diabetes-Associated Variation in TCF7L2 Is Not Associated With Hepatic or Extrahepatic Insulin Resistance.

Authors:  Ron T Varghese; Ivan Viegas; Cristina Barosa; Catia Marques; Meera Shah; Robert A Rizza; John G Jones; Adrian Vella
Journal:  Diabetes       Date:  2016-01-28       Impact factor: 9.461

Review 8.  Measurements of Gluconeogenesis and Glycogenolysis: A Methodological Review.

Authors:  Stephanie T Chung; Shaji K Chacko; Agneta L Sunehag; Morey W Haymond
Journal:  Diabetes       Date:  2015-12       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.